BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28673314)

  • 1. Cardiovascular disease risk profiles in inflammatory joint disease entities.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Arthritis Res Ther; 2017 Jul; 19(1):153. PubMed ID: 28673314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases.
    Wibetoe G; Ikdahl E; Rollefstad S; Olsen IC; Bergsmark K; Kvien TK; Salberg A; Soldal DM; Bakland G; Lexberg Å; Fevang BT; Gulseth HC; Haugeberg G; Semb AG
    Int J Cardiol; 2018 Feb; 252():201-206. PubMed ID: 29249429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.
    Ikdahl E; Wibetoe G; Rollefstad S; Salberg A; Bergsmark K; Kvien TK; Olsen IC; Soldal DM; Bakland G; Lexberg Å; Fevang BTS; Gulseth HC; Haugeberg G; Semb AG
    Int J Cardiol; 2019 Jan; 274():311-318. PubMed ID: 30007486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.
    Rollefstad S; Kvien TK; Holme I; Eirheim AS; Pedersen TR; Semb AG
    Ann Rheum Dis; 2013 Dec; 72(12):1968-74. PubMed ID: 23264359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.
    Castañeda S; González-Juanatey C; González-Gay MA
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):278-292. PubMed ID: 28852999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.
    Semb AG; Ikdahl E; Hisdal J; Olsen IC; Rollefstad S
    Int J Cardiol; 2016 Nov; 223():331-336. PubMed ID: 27543704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
    Agca R; Heslinga SC; Rollefstad S; Heslinga M; McInnes IB; Peters MJ; Kvien TK; Dougados M; Radner H; Atzeni F; Primdahl J; Södergren A; Wallberg Jonsson S; van Rompay J; Zabalan C; Pedersen TR; Jacobsson L; de Vlam K; Gonzalez-Gay MA; Semb AG; Kitas GD; Smulders YM; Szekanecz Z; Sattar N; Symmons DP; Nurmohamed MT
    Ann Rheum Dis; 2017 Jan; 76(1):17-28. PubMed ID: 27697765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden.
    Brenner P; Askling J; Hägg D; Brandt L; Stang P; Reutfors J
    Gen Hosp Psychiatry; 2024; 89():23-31. PubMed ID: 38714100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis.
    Favarato MH; Mease P; Gonçalves CR; Gonçalves Saad C; Sampaio-Barros PD; Goldenstein-Schainberg C
    Clin Exp Rheumatol; 2014; 32(2):182-7. PubMed ID: 24480317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
    John H; Kitas G
    Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
    Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
    Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV
    J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease-results from the nationwide Norwegian Cardio-rheuma registry.
    Ikdahl E; Rollefstad S; Kazemi A; Provan SA; Larsen TL; Semb AG
    Eur Heart J Cardiovasc Pharmacother; 2024 Jan; 10(1):27-34. PubMed ID: 37881093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden.
    Landgren AJ; Dehlin M; Jacobsson L; Bergsten U; Klingberg E
    RMD Open; 2021 May; 7(2):. PubMed ID: 34031261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
    Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degree of arterial stiffness is comparable across inflammatory joint disease entities.
    Föhse FK; Rollefstad S; Ikdahl E; Wibetoe G; Sexton J; Hisdal J; Semb AG
    Scand J Rheumatol; 2022 May; 51(3):186-195. PubMed ID: 34132621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.